BNTC EBITDA Growth
Benitec Biopharma Inc · EBITDA Growth
BNTC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-4.11%period ending
BNTC TTM EBITDA YoY % (-121.47% → -4.11%)
Year-over-year change
High-resolution chart · PNG
BNTC ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -4.1058% | |
| -44.3502% | |
| -113.5775% | |
| -141.2047% | |
| -122.0293% | |
| -75.3314% | |
| -21.0061% | |
| -9.1313% | |
| -14.2121% | |
| -7.5889% | |
| -15.5885% | |
| -12.3149% | |
| -8.0128% | |
| -18.6846% | |
| -7.5885% | |
| -14.0955% | |
| -33.9358% | |
| -34.2122% | |
| -44.9664% | |
| -34.196% | |
| -24.8927% | |
| -24.2991% | |
| -31.9096% | |
| -429.8274% | |
| -402.5666% | |
| -379.2081% | |
| -329.6044% | |
| -38.6661% | |
| 147.5944% | |
| 152.7264% | |
| 183.2014% | |
| 69.2491% | |
| -160.2736% | |
| -79.5742% | |
| 11.0368% | |
| 35.6932% | |
| 77.9229% | |
| 74.4548% | |
| 63.6638% | |
| 34.9799% | |
| -18.5917% | |
| -73.6032% | |
| -64.8494% | |
| -50.909% | |
| -47.136% | |
| -35.1883% | |
| -71.0062% | |
| -92.5227% | |
| -121.4693% |